Zymeworks Inc. (ZYME) CEO Ken Galbraith on Q2 2022 Results -

Zymeworks Inc. (NYSE:NYSE:ZYME) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Ken Galbraith - Chair...

Related Keywords

Paris , France General , France , New York , United States , Memorial Sloan Kettering Cancer Center , Vancouver , British Columbia , Canada , Delaware , New York Stock Exchange , Canadian , American , Ken Galbraith , Neil Josephson , Paul Moore , Stephen Willey , Akash Tewari , Komal Jhaveri , Gena Wang , Charles Zhu , Neil Klompas , Amy Li , Yigal Nochomovitz , Jack Spinks , Nick Abbott , Company Participants , York Stock Exchange , Zymeworks Inc , European Society Of Medical Oncology , European Society For Medical Oncology Conference , Zymeworks Delaware Inc , Barclays , Wells Fargo , Conference Call August , Zymeworks Second Quarter , Conference Call , Associate Director , Investor Relations , Zymeworks Delaware , Chief Executive Officer , Chief Operating , Chief Scientific , Chief Scientific Officer , Annual Meeting , American Society , Clinical Oncology , European Society , Medical Oncology , Medical Oncology Conference ,